KRAS and glioblastoma: These findings are consistent with the finding that RAS and TGFB1 cooperate to induce EMT in epithelial cells and evidence that KRAS activation in glioblastoma cells induces a mesenchymal shift (Kim et al. 2014; Marques et al. 2021; Zhao et al. 2021).